Regulation & policy

What do US tariffs against India mean for botanical exports?

What do US tariffs against India mean for botanical exports?

By Claudia Adrien

President Trump implemented 50% tariffs on goods from India 10 days ago in retaliation for India’s importation of Russian oil. According to the BBC, prolonged 50% tariffs could ‘shave off’ as much as 0.8% of India’s GDP.

UK teen energy drink ban: Is caffeine really the culprit?

UK teen energy drink ban: Is caffeine really the culprit?

By Olivia Haslam

The UK government will consult on banning high-caffeine energy drinks for under-16s in England over health concerns. However, a new study suggests energy drinks may only be indirectly linked to poor adolescent health, so what makes them risky?

AHPA launches kava working group amid regulatory action

AHPA launches kava working group amid regulatory action

By Asia Sherman

The American Herbal Products Association (AHPA) has formed a new working group on kava in response to recent regulatory actions in Michigan and New York City that affect the availability and sale of kava products.

Phoenix oyster mushroom mycelium ruled as novel

Phoenix oyster mushroom mycelium ruled as novel

By Olivia Haslam

The mycelium of the Phoenix oyster mushroom is confirmed as a novel food following a recent consultation by German authorities, but according to an expert, this might not be a bad thing for most formulators and consumers.

Florida bans 7-OH amid opioid abuse concerns

Florida bans 7-OH amid opioid abuse concerns

By Claudia Adrien

The Florida Office of the Attorney General filed an emergency rule on Wednesday classifying concentrated 7-hydroxymitragynine (7-OH) as a Schedule 1 controlled substance in the state.

Leaked MAHA draft promotes deregulation and voluntary compliance

Leaked MAHA draft promotes deregulation and voluntary compliance

By Elizabeth Crawford

Critics warn the Trump administration’s deregulatory approach and preference for voluntary change, reflected in the second draft of t Make America Healthy Again report, could make America ‘sicker, hungrier and more at risk from unsafe food

Alkemist watch list: Which ingredients made the naughty list?

Alkemist watch list: Which ingredients made the naughty list?

By Danielle Masterson

With the goal to help the industry continually improve product quality, Alkemist Labs has released its 2025 “Herbs & Fungi We’re Watching” list, which features 20 ingredients that the lab says requires extra scrutiny.

Navigating botanical safety: How useful is EFSA’s plant compendium?

Navigating botanical safety: How useful is EFSA’s plant compendium?

By Lauren Nicolle

EFSA recently released an updated version of the Compendium of Botanicals, an open-source database of thousands of plant species that are reported to contain substances of potential concern. But how valuable is this tool for botanical supplement...

Kava off the menu in NYC

Kava off the menu in NYC

By Danielle Masterson

Restaurants in New York City can no longer serve kava drinks, following a recent ruling on steeped kava beverages.

Tariffs: Supplement industry responds to new EU-US trade deal

Tariffs: Supplement industry responds to new EU-US trade deal

By Lauren Nicolle

Following months of apprehension, US president Donald Trump and European Commission president Ursula von der Leyen finally struck a trade deal which will see EU goods incur a 15% tariff in the US. But what does this mean for the European dietary...

South Korea bans imports of supplements containing 7-OH

South Korea bans imports of supplements containing 7-OH

By Tingmin Koe

South Korea’s Ministry of Food and Drug Safety (MFDS) has an import ban on dietary supplements, jellies, and beverages containing 7-hydroxymitragynine (7-OH) and has urged consumers to refrain from these products when doing cross-border e-commerce (CBEC)...

FDA clamps down on proliferation of 7-OH products

FDA clamps down on proliferation of 7-OH products

By Claudia Adrien

The U.S. Food and Drug Administration announced on Tuesday that it is recommending a scheduling action to control certain 7-hydroxymitragynine (7-OH) products under the Controlled Substances Act.

Short-staffed FDA delays NMN citizen petition response

Short-staffed FDA delays NMN citizen petition response

By Asia Sherman

The U.S. Food and Drug Administration (FDA) has delayed its response to a citizen petition regarding nicotinamide mononucleotide (NMN), citing agency-wide staffing reductions and administrative setbacks.

The making of the MAHA moms

The making of the MAHA moms

By Danielle Masterson

The UNPA’s recent State & Federal Affairs Update Member Webinar covered various topics such as tariffs, the president’s megabill and budget cuts. However, the primary focus was on the emergence of the “Make America Healthy Again” moms and their...

FTC warns companies about ‘Made in USA’ compliance requirements

FTC warns companies about ‘Made in USA’ compliance requirements

By Stephen Daniells

The Federal Trade Commission sent four warning letters this week to companies that claim their products are “Made in USA” and sent letters to Amazon and Walmart explaining how the commission’s requirements apply to online marketplaces.